VIPoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
Madhu Sigdel (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{VIPoma}} | {{VIPoma}} | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}}{{Homa}} | ||
==Overview== | ==Overview == | ||
VIPoma also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison. | VIPoma which is also known as [[Verner-Morrison syndrome]] was first described in 1958 by Verner and Morrison. | ||
==Historical Perspective== | ==Historical Perspective== | ||
* In 1870, Rudolf Heidenhain was the first to discover and describe the [[neuroendocrine tumors]] of the [[gastrointestinal tract]] and [[pancreas]]. | |||
* In 1958, American [[physicians]], John U. Verner and Ashton B. Morrison discovered VIPoma for the first time in a [[patient]] presenting with profuse [[diarrhea]] and [[hypokalemia]]. | |||
* John U. Verner and Ashton B also described the [[pathogenesis]] of VIPoma (due to [[malignancy]] of non-[[insulin]] producing [[pancreatic islets]]) in detail. | |||
* VIPoma is also known as [[Verner-Morrison syndrome]].<ref name="pmid287302202">{{cite journal| author=Belei OA, Heredea ER, Boeriu E, Marcovici TM, Cerbu S, Mărginean O et al.| title=Verner-Morrison syndrome. Literature review. | journal=Rom J Morphol Embryol | year= 2017 | volume= 58 | issue= 2 | pages= 371-376 | pmid=28730220 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28730220 }}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Medicine]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Endocrinology]] | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Latest revision as of 00:40, 30 July 2020
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma historical perspective On the Web |
|
American Roentgen Ray Society Images of VIPoma historical perspective |
|
Risk calculators and risk factors for VIPoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3] Homa Najafi, M.D.[4]
Overview
VIPoma which is also known as Verner-Morrison syndrome was first described in 1958 by Verner and Morrison.
Historical Perspective
- In 1870, Rudolf Heidenhain was the first to discover and describe the neuroendocrine tumors of the gastrointestinal tract and pancreas.
- In 1958, American physicians, John U. Verner and Ashton B. Morrison discovered VIPoma for the first time in a patient presenting with profuse diarrhea and hypokalemia.
- John U. Verner and Ashton B also described the pathogenesis of VIPoma (due to malignancy of non-insulin producing pancreatic islets) in detail.
- VIPoma is also known as Verner-Morrison syndrome.[1]
References
- ↑ Belei OA, Heredea ER, Boeriu E, Marcovici TM, Cerbu S, Mărginean O; et al. (2017). "Verner-Morrison syndrome. Literature review". Rom J Morphol Embryol. 58 (2): 371–376. PMID 28730220.